With consistent daily application as part of a supervised hair health protocol, Hair: GHK-Cu supports:

A healthier scalp microenvironment through copper-dependent extracellular matrix remodeling and enzyme activation

Improved perifollicular microcirculation through VEGF-associated angiogenic activity

Potential prolongation of the anagen (active growth) phase through TGF-β1 suppression

Support for dermal papilla cell viability and proliferative capacity

Engagement of Wnt/β-catenin follicular signaling pathways

Reduced perifollicular inflammatory burden through GHK-Cu's documented anti-inflammatory activity

Improved hair shaft diameter and structural quality with consistent long-term use, as suggested by historical cosmetic data

Reduced hair shedding in patients with compromised follicular environments

Support for scalp tissue integrity and perifollicular collagen organization

A biological foundation that complements other hair loss therapies when used as part of a comprehensive provider-supervised protocol

Results vary significantly by individual, underlying cause of hair loss, and treatment duration. Hair follicle biology operates on the timescale of the hair growth cycle — typically three to six months for a single complete cycle. Meaningful cosmetic changes, including improvements in hair density, shaft diameter, and shedding rate, generally require a minimum of three to six months of consistent daily application. Continued use is typically required to maintain any gains achieved. Hair: GHK-Cu is not a replacement for established medical treatments for diagnosed hair loss conditions; discuss comprehensive hair loss management with your provider.

Apply once to twice daily, preferably in the evening on a clean, dry scalp.

Application Instructions:

Cleanse the scalp with your regular shampoo and allow to dry completely before applying. Application to clean, dry scalp improves penetration and reduces dilution of the active.

Part the hair to expose the thinning or affected scalp areas targeted for treatment.

Using the included dropper, apply approximately 1–2 mL of solution directly to the affected scalp regions, distributing small aliquots across the treatment area in sections.

Using the fingertips, gently massage the solution into the scalp with circular motions to facilitate even coverage and enhance absorption into the perifollicular tissue.

Do not rinse. Allow to dry and absorb before styling.

Wash hands after application.

Evening application is preferred — allowing the solution to remain undisturbed on the scalp through overnight hours maximizes contact time with the follicular environment and avoids removal by daytime styling products, sweat, or environmental exposure.

If a dose is missed: Apply when remembered on the same day, or resume the regular schedule at the next planned administration. Do not double-dose to compensate for a missed application.

Treatment duration: Plan for a minimum three-to-six-month treatment course before assessing cosmetic response. Hair biology moves slowly — premature assessment leads to premature discontinuation of therapies that require time to produce results. Any deviations from your prescriber's specific instructions should be discussed with your supervising clinician.

Hair: GHK-Cu is a prescription-only compounded medication. Patients must be counseled before initiating therapy.

Contraindications:

Known copper sensitivity or allergy: Patients with documented hypersensitivity to copper, copper salts, or copper peptide compounds should not use this product.

Active scalp infection or inflammation: Do not apply to scalp areas affected by active bacterial, fungal (including tinea capitis), or viral infection, or to actively inflamed, broken, or acutely irritated scalp skin.

Wilson's disease or copper metabolism disorders: GHK-Cu delivers bioavailable copper to skin tissue. Patients with Wilson's disease or other diagnosed copper metabolism disorders should not use this product without explicit discussion with their specialist — the clinical relevance of topical copper delivery in these conditions requires individualized medical evaluation.

Pregnancy and breastfeeding: Safety of topical GHK-Cu during pregnancy and lactation has not been established. Consult your provider before use.

Potential Side Effects:

Adverse reactions to topical GHK-Cu are uncommon in published experience and post-marketing reports, and when they occur tend to be mild and localized:

Common:

Transient erythema (redness), pruritus (itching), or mild stinging at the application site — typically resolving with continued use or brief treatment interruption; often most pronounced in the first one to two weeks of use

Less common:

Scalp dryness or flaking, particularly when used alongside other desiccating scalp products or in dry-climate environments; reducing application frequency or adding an emollient adjunct typically mitigates this

Mild transient scalp sensitivity during the initial adjustment period

Rare:

Allergic contact dermatitis with prolonged copper exposure — persistent or worsening inflammation, spreading rash, or vesiculation should prompt discontinuation and medical evaluation

No serious systemic adverse events attributable to topical GHK-Cu have been documented in the published literature to date; however, comprehensive long-term surveillance data remain limited

Note on initial shedding: Some patients experience a brief increase in hair shedding during the first four to six weeks of treatment — a phenomenon observed with several hair growth therapies as follicles in prolonged resting phase are pushed toward cycling activity. This is typically transient and resolves as the treatment effect establishes. Discuss any concerns about increased shedding with your provider before discontinuing.

Discontinue use and contact your provider if: persistent or worsening scalp inflammation, allergic reaction signs, or unexpected systemic symptoms develop.

Other topical scalp treatments: Hair: GHK-Cu can be used as part of a comprehensive hair loss protocol that includes other topical agents. When combining with other scalp treatments, apply in sequence with adequate absorption time between products. Discuss all concurrent scalp treatments with your provider to optimize sequencing.

Minoxidil: GHK-Cu and minoxidil address distinct and complementary mechanisms — GHK-Cu targeting follicular biology and extracellular matrix, minoxidil promoting vasodilation and potassium channel-mediated follicular effects. Concurrent use may be prescribed as part of a provider-designed combination protocol; do not self-combine without guidance.

Topical finasteride or spironolactone: Anti-androgenic topical agents may be prescribed alongside GHK-Cu in patients with hormonally driven hair loss; the mechanisms are non-overlapping and complementary. Follow your provider's specific sequencing instructions.

High-dose oral zinc supplementation: Zinc and copper compete for absorption and can mutually reduce bioavailability. High-dose zinc supplementation may theoretically reduce the biological activity of topically delivered copper. Discuss significant zinc supplementation with your provider.

Copper-chelating topical agents: Certain skincare ingredients with copper-chelating properties may theoretically reduce GHK-Cu activity if applied to the same scalp area. Discuss concurrent topical product use with your provider.

Store at room temperature, 68°F – 77°F (20°C – 25°C), away from direct heat, humidity, and light

Keep container tightly closed between uses

Do not freeze

Keep out of reach of children

Do not use beyond the labeled expiration date

The solution may have a characteristic color from the copper complex — this is normal and does not indicate degradation